FDA authorises first COVID-19 test available without a prescription that also detects influenza and RSV

FDA

16 May 2022 - The EUA authorises at home sample collection with testing performed in a laboratory.

Today, the U.S. FDA authorised the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription by individuals with symptoms of respiratory viral infection consistent with COVID-19.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder